{
     "PMID": "25779040",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160208",
     "LR": "20161125",
     "IS": "1872-6240 (Electronic) 0006-8993 (Linking)",
     "VI": "1611",
     "DP": "2015 Jun 22",
     "TI": "Excitotoxicity induced by kainic acid provokes glycogen synthase kinase-3 truncation in the hippocampus.",
     "PG": "84-92",
     "LID": "10.1016/j.brainres.2015.03.016 [doi] S0006-8993(15)00198-5 [pii]",
     "AB": "In neuronal cultures, glycogen synthase kinase 3(GSK3) is truncated at the N-terminal end by calpain downstream of activated glutamate receptors. However, the in vivo biological significance of that truncation has not been explored. In an attempt to elucidate if GSK3 truncation has a pathophysiological relevance, we have used intraperitoneal injections of kainic acid (KA) in rats and intra-amygdala KA microinjections in mice as in vivo models of excitotoxicity. Spectrin cleavage analyzed by immunohistochemistry was observed in the CA1 hippocampal field in KA-intraperitoneal treated rats while the CA3 region was the hippocampal area affected after intra-amygdala KA microinjections. GSK3beta immunofluorescence did not colocalize with truncated spectrin in both treatments using an antibody that recognize the N-terminal end of GSK3beta. Thus, those neurons which are spectrin-positive do not show GSK3beta immunolabelling. To study GSK3beta truncation in vitro, we exposed organotypic hippocampal slices and cultured cortical neurons to KA leading to the truncation of GSK3 and we found that truncation was blocked by the calpain inhibitor calpeptin. These data suggest a relationship between N-terminal GSK3beta truncation and excitotoxicity. Overall, our data reinforces the important relationship between glutamate receptors and GSK3 and their role in neurodegenerative processes in which excitotoxicity is involved.",
     "CI": [
          "Copyright (c) 2015 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Jurado-Arjona, Jeronimo",
          "Goni-Oliver, Paloma",
          "Rodriguez-Prada, Lucia",
          "Engel, Tobias",
          "Henshall, D C",
          "Avila, Jesus",
          "Hernandez, Felix"
     ],
     "AU": [
          "Jurado-Arjona J",
          "Goni-Oliver P",
          "Rodriguez-Prada L",
          "Engel T",
          "Henshall DC",
          "Avila J",
          "Hernandez F"
     ],
     "AD": "Centro de Biologia Molecular \"Severo Ochoa\", CSIC/UAM, Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, Spain; CIBERNED, Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas, 28031 Madrid, Spain. Centro de Biologia Molecular \"Severo Ochoa\", CSIC/UAM, Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, Spain. Centro de Biologia Molecular \"Severo Ochoa\", CSIC/UAM, Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, Spain. Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland. Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland. Centro de Biologia Molecular \"Severo Ochoa\", CSIC/UAM, Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, Spain; CIBERNED, Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas, 28031 Madrid, Spain. Centro de Biologia Molecular \"Severo Ochoa\", CSIC/UAM, Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, Spain; CIBERNED, Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas, 28031 Madrid, Spain. Electronic address: fhernandez@cbm.csic.es.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150314",
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Antibodies)",
          "0 (Excitatory Amino Acid Agonists)",
          "12634-43-4 (Spectrin)",
          "EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta)",
          "EC 2.7.11.1 (Gsk3b protein, mouse)",
          "EC 2.7.11.1 (Gsk3b protein, rat)",
          "EC 2.7.11.26 (Glycogen Synthase Kinase 3)",
          "SIV03811UC (Kainic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Amygdala/drug effects",
          "Animals",
          "Antibodies",
          "Cells, Cultured",
          "Disease Models, Animal",
          "Excitatory Amino Acid Agonists/*toxicity",
          "Glycogen Synthase Kinase 3/immunology/*metabolism",
          "Glycogen Synthase Kinase 3 beta",
          "Hippocampus/drug effects/*enzymology",
          "Kainic Acid/*toxicity",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Neurons/drug effects/*enzymology",
          "Rats",
          "Rats, Wistar",
          "Spectrin/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Calpain",
          "Excitotoxicity",
          "Glycogen synthase kinase-3 (GSK3)",
          "Hippocampus",
          "Kainic acid (KA)",
          "Proteolysis"
     ],
     "EDAT": "2015/03/18 06:00",
     "MHDA": "2016/02/09 06:00",
     "CRDT": [
          "2015/03/18 06:00"
     ],
     "PHST": [
          "2015/02/04 00:00 [received]",
          "2015/03/06 00:00 [accepted]",
          "2015/03/18 06:00 [entrez]",
          "2015/03/18 06:00 [pubmed]",
          "2016/02/09 06:00 [medline]"
     ],
     "AID": [
          "S0006-8993(15)00198-5 [pii]",
          "10.1016/j.brainres.2015.03.016 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2015 Jun 22;1611:84-92. doi: 10.1016/j.brainres.2015.03.016. Epub 2015 Mar 14.",
     "term": "hippocampus"
}